A woman who used to collapse mid-meal can now eat a full dinner without fear of blacking out, thanks to a heart procedure most Americans have never heard of.
Quick Take
- Cardioneuroablation is a catheter procedure that targets nerve clusters on the heart to stop repeated fainting spells.
- Doctors use it for vasovagal syncope, a condition where the body overreacts to triggers like standing, heat, or eating.
- Clinical studies report freedom from fainting in roughly 88 to 94 percent of patients after the procedure.
- Mayo Clinic calls it a promising option for patients whose fainting keeps coming back despite other treatments.
Why Fainting Spells Become a Real Problem
Vasovagal syncope is the medical name for common fainting. Mayo Clinic notes it is usually harmless and often needs no treatment at all. But for some patients, the fainting spells strike often and without warning, turning simple activities like eating, standing in line, or driving into daily risks.
Conventional treatment usually means lifestyle changes, more salt and fluids, or compression stockings. When those steps fail and fainting keeps happening, doctors call the condition refractory. That is where cardioneuroablation enters the conversation as a targeted fix rather than a workaround.
The procedure targets ganglionated plexi, small nerve clusters embedded in the heart’s outer wall. These clusters help control the vagus nerve’s signals to the heart. In vasovagal syncope, those signals can misfire, slowing the heart rate or dropping blood pressure so fast that a person passes out.
What The Procedure Actually Does
Doctors thread a catheter through a blood vessel into the heart, then use radiofrequency energy to disable the overactive nerve clusters. The goal is to rebalance the heart’s autonomic nervous system so it stops triggering fainting in response to normal stress or standing. It is done in a lab, not open surgery.
A first U.S. case report described a patient who stayed completely free of fainting and warning symptoms eighteen months after the procedure. That single case matched a growing pattern doctors were seeing in small studies overseas, which pushed more American hospitals to study the approach seriously.
The Numbers Behind The Optimism
A major meta-analysis pooling data from 27 observational studies and one randomized trial, covering 1,153 patients, found the syncope recurrence rate after the procedure sat at just under 6 percent. Put another way, more than 94 out of 100 patients stopped fainting after the ablation.
An earlier systematic review found freedom from fainting at 91.9 percent, with a very low variation between studies, meaning the results held up across different hospitals and patient groups. A separate review tracking patients for a median of 8.5 months found freedom from syncope at 93.3 percent, with monthly fainting episodes dropping from more than one and a half per month to nearly zero.
The strongest evidence comes from a 2025 randomized clinical trial comparing two versions of the procedure: one that ablates only the left side of the heart, and one that treats both sides. The left-side-only approach hit 87.5 percent efficacy, while the two-sided approach hit 90 percent, and researchers confirmed the simpler, left-side option was not meaningfully worse. That matters because a shorter, simpler procedure with nearly identical results means less time under anesthesia and fewer catheter insertions for patients.
How Mayo Clinic Frames The Treatment
Mayo Clinic’s own cardiovascular podcast described cardioneuroablation as a promising new catheter option specifically for patients whose vasovagal syncope has resisted standard treatment. Guest experts on the program walked through how the procedure works and which patients tend to benefit most, generally those under 60 with severe, recurrent fainting and no reliable warning symptoms beforehand.
Researchers running an ongoing clinical trial are still comparing cardioneuroablation directly against standard non-drug treatment, aiming to measure not just whether fainting stops, but how the heart’s underlying nerve regulation changes over time. That kind of head-to-head comparison is exactly what turns a promising procedure into a standard one doctors nationwide feel confident recommending.
For patients who have spent years avoiding restaurants, standing in lines, or even simple errands out of fear of collapsing, a procedure with success rates above 85 percent represents more than a medical footnote. It represents getting a normal life back.
Sources:
pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov, cardiovascularservices.mayoclinic.com, clinicaltrials.gov, mayoclinic.org, jacc.org
